Results 131 to 140 of about 4,412 (151)

Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka. [PDF]

PLOS Glob Public Health, 2022
Jeewandara C, Jayampathi KACS, Ranasinghe T, Aberathna IS, Gunasekara B, Danasekara S, Nimasha T, Kuruppu H, Dissanayake O, Gamalath N, Ekanayake D, Jayamali J, Somathilake G, Guruge D, Wijayamuni R, Kamaladasa A, Ogg GS, Malavige GN.   +17 more
europepmc   +1 more source

Thrombotic thrombocytopenia After Sinopharm BBIBP-CorV COVID-19 vaccination. [PDF]

Res Pract Thromb Haemost, 2022
Hosseinzadeh R, Barary M, Mehdinezhad H, Sio TT, Langer F, Khosravi S.   +5 more
europepmc   +1 more source

FAKHRAVAC and BBIBP-CorV vaccine seeds’ binding to angiotensin-converting enzyme 2: A comparative molecular dynamics study

, 2023
Setareh S, Rad I, Meghdadi J, Khodayari K, Karimi Rahjerdi A.   +4 more
europepmc   +1 more source

Immunogenicity, clinical efficacy, and safety of the sinopharm (BBIBP-CorV) SARS-CoV-2 vaccine among people with multiple sclerosis receiving disease-modifying therapies: a prospective cohort study. [PDF]

BMC Neurol
Jameie M, Azizmohammad Looha M, Ebadi Z, Amanollahi M, Amani K, Nobahari F, Abdollahi A, Mousavi M, Pourghaz B, Harirchian MH.   +9 more
europepmc   +1 more source

Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population. [PDF]

PLoS One
Theresa Pool SN, Shroff EH, Chetty A, Lewis L, Nonhlanhla YZ, Abdool Karim SS.   +5 more
europepmc   +1 more source

Effectiveness of Sinopharm's BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave. [PDF]

Vaccines (Basel)
Belayachi J, Mhayi A, Majidi H, El Fahime E, Abouqal R.   +4 more
europepmc   +1 more source

Safety and Immunogenicity of the NVX-CoV2373 Vaccine as a Booster in Adults Previously Vaccinated with the BBIBP-CorV Vaccine: An Interim Analysis

, 2023
Toback S, Marchese AM, Warren B, Ayman S, Zarkovic S, ElTantawy I, Mallory RM, Rousculp M, Almarzooqi F, Piechowski-Jozwiak B, Bonilla M, Bakkour AE, Hussein SE, Kaabi NA.   +13 more
europepmc   +1 more source